. 2012 Aug 14;3:250. doi: 10.3389/fimmu.2012.00250

Table 4.

Selected clinical trials of microbicides.

Microbicides	Status	Phase	Type of prevention	Alternate study ID	Component	Comment/references
NCT00262106	Complete	III	Gel, vaginal	MDP301, ISRCTN64716212	PRO 2000/5 gel 0.5% and 2%	Not efficacious; McCormack et al., 2010
NCT00153777	Terminated	III	Gel, vaginal	CONRAD, C03-090	Cellulose sulfate gel (6%)	No protection, possible enhancement; Van Damme et al., 2008
NCT00213083	Unknown	III	Gel, vaginal	Population council #322	Carraguard (PC-515)	No protection; Skoler-Karpoff et al., 2008
NCT00441298	Complete	II	Gel, vaginal	CAPRISA 004	Tenofovir 1% gel	39% efficacy; Abdool Karim et al., 2010
NCT00705679	Active	II	Gel, vaginal and ART oral	VOICE, MTN-003	Tenofovir 1% vaginal gel, emtricitabine/tenofovir disoproxil fumarate	Vaginal gel arm halted, no efficacy; 1
NCT00740584	Complete	I/II	Gel, vaginal	SPL7013-003, DAIDS ES number 10730	3% SPL7013 gel (VivaGel)	Price et al., 2011
NCT00850837	Recruiting	I	Gel, vaginal	AF 020	Acidform lubricant (Amphora)	–
NCT01283360	Recruiting	I	Gel, rectal	CONRAD, 1009001	Tenofovir 1% gel	–

More information about the individual trials can be found using the NCT number and the following databases: www.aidsinfo.nih.gov/clinical-trials; www.clinicaltrials.gov; http://www.avac.org.